Yingxiao C. Li
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Metformin Induces PARP1-mediated Cell Death in NPC/HK1 Human Nasopharyngeal Carcinoma Cells.
Journal: Anticancer research
Published: January 31, 2026
Bis-type Triaziquone Induces PARP1-mediated Cell Death in Human NPC/HK1 Nasopharyngeal Carcinoma Cells.
Journal: Anticancer research
Published: August 15, 2025
Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Enhance Cisplatin-induced Apoptotic Effects via the ROS-Fas Pathway in Human NPC-TW01 Nasopharyngeal Carcinoma Cells.
Journal: Anticancer research
Published: May 22, 2025
Serum Starvation-induced ROS Production Activates the ERK-AP-1-TfR1 Pathway to Up-regulate Survivin to Support Nasopharyngeal Carcinoma Cell Viability.
Journal: Cancer genomics & proteomics
Published: March 06, 2025
Syringaldehyde Alleviates Cardiac Hypertrophy Induced by Hyperglycemia in H9c2 Cells Through GLP-1 Receptor Signals.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 26, 2024
Scutellarein enhances cisplatin‑induced apoptotic effects by suppressing the PI3K/AKT‑MDR1 pathway in human NPC/HK1 nasopharyngeal carcinoma cells.
Journal: Biomedical reports
Published: October 03, 2024
Development of Syringaldehyde as an Agonist of the GLP-1 Receptor to Alleviate Diabetic Disorders in Animal Models.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 15, 2024
Identification of Andrographolide as an Agonist of Bile Acid TGR5 Receptor in a Cell Line to Demonstrate the Reduction in Hyperglycemia in Type-1 Diabetic Rats.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 30, 2023
Bolus Injection of Liraglutide Raises Plasma Glucose in Normal Rats by Activating Glucagon-like Peptide 1 Receptor in the Brain.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 05, 2022
Last Updated: 09/26/2026